Tilson Financial Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$388K Buy
3,020
+89
+3% +$10.4K 0.11% 66
2026
Q1
$353K Hold
2,931
0.11% 65
2025
Q4
$309K Buy
2,931
+14
+0.5% +$1.31K 0.09% 70
2025
Q3
$245K Sell
2,917
-1
-0% -$82 0.08% 73
2025
Q2
$231K Sell
2,918
-2,047
-41% -$163K 0.09% 69
2025
Q1
$446K Buy
4,965
+132
+3% +$12.3K 0.18% 56
2024
Q4
$481K Buy
4,833
+16
+0.3% +$1.65K 0.2% 54
2024
Q3
$547K Hold
4,817
0.24% 49
2024
Q2
$596K Buy
4,817
+633
+15% +$81.5K 0.6% 21
2024
Q1
$552K Sell
4,184
-5
-0.1% -$616 0.3% 46
2023
Q4
$457K Hold
4,189
0.29% 46
2023
Q3
$431K Hold
4,189
0.34% 46
2023
Q2
$483K Buy
4,189
+6
+0.1% +$681 0.82% 20
2023
Q1
$445K Hold
4,183
0.36% 42
2022
Q4
$464K Buy
+4,183
New +$428K 0.4% 41

Other funds holding MRK

Tilson Financial Group's MRK Position: Q2 2026 in Review

Tilson Financial Group increased its Merck (MRK) stake by 3% in Q2 2026, buying an estimated $10.4K and bringing the position to 3,020 shares worth $388K. The position accounts for 0.11% of the portfolio, ranked #66.

Tilson Financial Group first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $596K in Q2 2024. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Tilson Financial Group held 3,020 shares of Merck worth $388K as of Q2 2026.
  • Tilson Financial Group bought 89 Merck shares in Q2 2026, an estimated $10.4K.
  • Merck made up 0.11% of Tilson Financial Group's portfolio in Q2 2026, its #66 holding.
  • Tilson Financial Group first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • Tilson Financial Group's Merck position peaked at $596K in Q2 2024.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Tilson Financial Group's 13F filing for Q2 2026, filed 27 Jul 2026.